Cytovation
Founded 2015 · 13 employees on LinkedIn · 1 known investors
Cytovation develops immunotherapy for cancer patients using novel peptide engineering to direct the immune system against solid tumors. Its technology targets a range of solid tumor types, particularly those driven by the Wnt/β-catenin signaling pathway.
Investors · 1
Frequently asked questions
- What does Cytovation do?
- Cytovation develops immunotherapy for cancer patients using novel peptide engineering to direct the immune system against solid tumors. Its technology targets a range of solid tumor types, particularly those driven by the Wnt/β-catenin signaling pathway.
- Who are Cytovation's investors?
- Cytovation's investors include Sandwater.